Clinical trial
Effectiveness of the Early Addition of Abacavir to an Anti-HIV Drug Combination
NCT00001132 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00001132 |
|---|---|
| Title | Effectiveness of the Early Addition of Abacavir to an Anti-HIV Drug Combination |
| Official title | A Pilot Study of Early Treatment Intensification of Antiretroviral Therapy |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Abacavir sulfate |
| Enrollment | 80 |
| Start date | Nov 1, 1999 |
| Completion | Apr 1, 2001 |
| First posted | Aug 31, 2001 |
| Last update posted | Sep 9, 2008 |
| Countries | Puerto Rico, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: